Tuesday, April 5, 2022

The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.


By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2

No comments:

Post a Comment